Our reputation says it all.
We changed the game when we commercialized our two best-in-class genomic tests, MammaPrint and BluePrint. They continue to provide physicians with vital information that can guide the course of a woman’s breast cancer treatment – ultimately, impacting her life and all those around her for the better.
Many of the world’s top medical minds trust in our science and the pristine data that supports it. We entreat you to trust in us as well – to work alongside respected thought leaders and scientists to further advance precision medicine.